Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rosemary M Cesario"'
Autor:
Thomas C Schulz, Holly Y Young, Alan D Agulnick, M Josephine Babin, Emmanuel E Baetge, Anne G Bang, Anindita Bhoumik, Igor Cepa, Rosemary M Cesario, Carl Haakmeester, Kuniko Kadoya, Jonathan R Kelly, Justin Kerr, Laura A Martinson, Amanda B McLean, Mark A Moorman, Janice K Payne, Mike Richardson, Kelly G Ross, Eric S Sherrer, Xuehong Song, Alistair Z Wilson, Eugene P Brandon, Chad E Green, Evert J Kroon, Olivia G Kelly, Kevin A D'Amour, Allan J Robins
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37004 (2012)
Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will require the translation of proof-of-principle concepts into a scalable, controlled, and regulated cell manufacturing process. We have previously demonstrated tha
Externí odkaz:
https://doaj.org/article/217b85207ea64dde8656ee24573940b2
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
Abstract Background Treatment with immune checkpoint inhibitors (ICIs) targeting CTLA-4 and the PD-1/PD-L1 axis is effective against many cancer types. However, due in part to unresponsiveness or acquired resistance, not all patients experience a dur
Externí odkaz:
https://doaj.org/article/82617a89986343a6a08c52f9f5ac5da5
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
BackgroundTreatment with immune checkpoint inhibitors (ICIs) targeting CTLA-4 and the PD-1/PD-L1 axis is effective against many cancer types. However, due in part to unresponsiveness or acquired resistance, not all patients experience a durable respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2784b6147dfb25067942d4144bf2a9dc
http://europepmc.org/articles/PMC8404302
http://europepmc.org/articles/PMC8404302
Autor:
Justin Kerr, Jonathan R. Kelly, Anindita Bhoumik, Mauro A. Frazier, Mark A. Moorman, Rosemary M. Cesario, Alan D. Agulnick, Robert Srijemac, Evert Kroon, Dana M. Ambruzs, Kevin A. D'Amour, Janice K. Payne, Alistair Wilson, Carl Haakmeester
The PEC-01 cell population, differentiated from human embryonic stem cells (hESCs), contains pancreatic progenitors (PPs) that, when loaded into macroencapsulation devices (to produce the VC-01 candidate product) and transplanted into mice, can matur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef1ce24f4e2aa0fbdf05d5d2fd00fa74
https://europepmc.org/articles/PMC4572906/
https://europepmc.org/articles/PMC4572906/
Publikováno v:
Cancer Letters. 240:225-233
This study evaluated the anti-tumor efficacy of combining the RXR agonist, bexarotene, with the PPARgamma agonist, rosiglitazone, in colon cancer. Moser, a human colon cancer cell line, was treated with bexarotene and rosiglitazone alone or in combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea1651aa97c8c5a3bbe16f5d5b091350
https://doi.org/10.1016/j.canlet.2005.09.010
https://doi.org/10.1016/j.canlet.2005.09.010
Autor:
Carl Haakmeester, Chad Green, Kuniko Kadoya, Mark A. Moorman, Janice K. Payne, Amanda B. McLean, Laura Martinson, Rosemary M. Cesario, Mike Richardson, Eric S. Sherrer, Evert Kroon, M. Josephine Babin, Justin Kerr, Igor Cepa, Alistair Wilson, Olivia Kelly, Allan J. Robins, Emmanuel E. Baetge, Kevin A. D'Amour, Eugene P. Brandon, Jonathan R. Kelly, Kelly G. Ross, Xuehong Song, Anindita Bhoumik, Anne G. Bang, Thomas C. Schulz, Alan D. Agulnick, Holly Y. Young
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37004 (2012)
PLoS ONE
PLoS ONE
Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will require the translation of proof-of-principle concepts into a scalable, controlled, and regulated cell manufacturing process. We have previously demonstrated tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7298272eaeb15ef99cb7d619a692a472
https://doi.org/10.1371/journal.pone.0037004
https://doi.org/10.1371/journal.pone.0037004